Qube Research & Technologies LTD Acadia Pharmaceuticals Inc Transaction History

Qube Research & Technologies LTD

$93.8 Billion
Q2 2025

A detailed history of Qube Research & Technologies LTD transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Qube Research & Technologies LTD holds 783,846 shares of ACAD stock, worth $17.8 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

783,846

Previous 649,210 20.74%

Holding current value

$17.8 Million

Previous $10.8 Million 56.79%

% of portfolio

0.02%

Previous 0.01%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$14.1 - $22.95 $1.9 Million - $3.09 Million	134,636 Added 20.74%	783,846 $16.9 Million
Q1 2025 May 15, 2025	BUY	$16.61 - $20.29 $295,458 - $360,918	17,788 Added 2.82%	649,210 $10.8 Million
Q4 2024 Feb 14, 2025	BUY	$14.29 - $18.76 $3.03 Million - $3.98 Million	212,019 Added 50.55%	631,422 $11.6 Million
Q3 2024 Nov 14, 2024	SELL	$15.14 - $19.14 $10.4 Million - $13.1 Million	-685,703 Reduced 62.05%	419,403 $6.45 Million
Q2 2024 Aug 14, 2024	BUY	$14.62 - $18.42 $6.74 Million - $8.49 Million	461,036 Added 71.58%	1,105,106 $18 Million
Q1 2024 May 14, 2024	BUY	$17.79 - $30.86 $6.47 Million - $11.2 Million	363,811 Added 129.81%	644,070 $11.9 Million
Q4 2023 Feb 13, 2024	BUY	$20.78 - $31.77 $1.4 Million - $2.14 Million	67,340 Added 31.63%	280,259 $8.77 Million
Q3 2023 Nov 13, 2023	BUY	$20.84 - $33.47 $3.92 Million - $6.3 Million	188,080 Added 757.2%	212,919 $4.44 Million
Q2 2023 Aug 14, 2023	BUY	$17.8 - $25.65 $442,134 - $637,120	24,839 New	24,839 $594,000
Q4 2022 Feb 14, 2023	BUY	$14.2 - $18.63 $436,238 - $572,332	30,721 New	30,721 $489,000
Q2 2022 Aug 15, 2022	SELL	$13.01 - $27.22 $166,853 - $349,096	-12,825 Closed	0 $0
Q1 2022 May 09, 2022	BUY	$20.94 - $27.5 $268,555 - $352,687	12,825 New	12,825 $311,000
Q1 2021 May 14, 2021	SELL	$25.02 - $54.99 $1.21 Million - $2.65 Million	-48,226 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$41.04 - $56.79 $1.98 Million - $2.74 Million	48,226 New	48,226 $2.58 Million
Q3 2020 Nov 12, 2020	SELL	$36.42 - $57.0 $5.88 Million - $9.2 Million	-161,431 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$39.26 - $52.73 $6.34 Million - $8.51 Million	161,431 New	161,431 $7.83 Million
Q1 2020 May 15, 2020	SELL	$31.65 - $46.87 $188,001 - $278,407	-5,940 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$36.21 - $51.4 $215,087 - $305,316	5,940 New	5,940 $254,000

Others Institutions Holding ACAD

# of Institutions

350

Shares Held

164M

Call Options Held

811K

Put Options Held

334K

View Full List

About ACADIA PHARMACEUTICALS INC

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $3.67B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

More about ACAD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.

Account

Qube Research & Technologies LTD Acadia Pharmaceuticals Inc Transaction History